JP2013103902A5 - - Google Patents

Download PDF

Info

Publication number
JP2013103902A5
JP2013103902A5 JP2011248309A JP2011248309A JP2013103902A5 JP 2013103902 A5 JP2013103902 A5 JP 2013103902A5 JP 2011248309 A JP2011248309 A JP 2011248309A JP 2011248309 A JP2011248309 A JP 2011248309A JP 2013103902 A5 JP2013103902 A5 JP 2013103902A5
Authority
JP
Japan
Prior art keywords
group
methyl
external preparation
general formula
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011248309A
Other languages
English (en)
Japanese (ja)
Other versions
JP5926931B2 (ja
JP2013103902A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2011248309A priority Critical patent/JP5926931B2/ja
Priority claimed from JP2011248309A external-priority patent/JP5926931B2/ja
Publication of JP2013103902A publication Critical patent/JP2013103902A/ja
Publication of JP2013103902A5 publication Critical patent/JP2013103902A5/ja
Application granted granted Critical
Publication of JP5926931B2 publication Critical patent/JP5926931B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011248309A 2011-11-14 2011-11-14 皮膚外用剤 Expired - Fee Related JP5926931B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011248309A JP5926931B2 (ja) 2011-11-14 2011-11-14 皮膚外用剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011248309A JP5926931B2 (ja) 2011-11-14 2011-11-14 皮膚外用剤

Publications (3)

Publication Number Publication Date
JP2013103902A JP2013103902A (ja) 2013-05-30
JP2013103902A5 true JP2013103902A5 (https=) 2014-12-25
JP5926931B2 JP5926931B2 (ja) 2016-05-25

Family

ID=48623725

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011248309A Expired - Fee Related JP5926931B2 (ja) 2011-11-14 2011-11-14 皮膚外用剤

Country Status (1)

Country Link
JP (1) JP5926931B2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3064416C (en) * 2014-04-03 2022-05-03 Pola Chemical Industries, Inc. Melanogenesis inhibitor comprising d-pantothenyl alcohol, and skin-whitening cosmetic containing same melanogenesis inhibitor
JP2022058065A (ja) * 2020-09-30 2022-04-11 株式会社ピカソ美化学研究所 アクチン再編成阻害剤、ファゴサイトーシス阻害剤、該阻害剤を含有するシミ形成抑制剤、並びに該抑制剤を含有する皮膚外用剤
CN113876614B (zh) * 2021-10-11 2023-05-02 广州萃普生物科技有限公司 一种甘草酸酐和金耳多糖降解产物复方组合物及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001122758A (ja) * 1999-10-22 2001-05-08 Pola Chem Ind Inc ＡＧＥｓ分解作用を有する老化肌防御、改善化粧料
JP2001131051A (ja) * 1999-11-09 2001-05-15 Pola Chem Ind Inc ＡＧＥｓ分解作用を有する老化肌防御、改善化粧料
JP2004262852A (ja) * 2003-03-03 2004-09-24 Kanebo Ltd 化粧料
JP4732854B2 (ja) * 2005-10-31 2011-07-27 一丸ファルコス株式会社 ペルオキシソーム増殖剤応答性受容体活性化剤
JP2007161661A (ja) * 2005-12-15 2007-06-28 Pola Chem Ind Inc アドバンスド・グリケーション・エンドプロダクツを分解するための化粧料とその製造法
JP2007161663A (ja) * 2005-12-15 2007-06-28 Pola Chem Ind Inc ＡＧＥｓ分解化粧料
JP2007161662A (ja) * 2005-12-15 2007-06-28 Pola Chem Ind Inc アドバンスド・グリケーション・エンドプロダクツ分解用の化粧料
JP2007161660A (ja) * 2005-12-15 2007-06-28 Pola Chem Ind Inc アドバンスド・グリケーション・エンドプロダクツを分解するための化粧料とその製造法
JP5424600B2 (ja) * 2008-09-16 2014-02-26 ポーラ化成工業株式会社 アドバンスド・グリケーション・エンドプロダクツ分解剤及び該アドバンスド・グリケーション・エンドプロダクツ分解剤を含有してなる化粧料
SG171722A1 (en) * 2008-12-22 2011-07-28 Pola Chem Ind Inc Melanin production inhibitor
JP5727151B2 (ja) * 2010-03-19 2015-06-03 ポーラ化成工業株式会社 ヒアルロン酸産生促進因子

Similar Documents

Publication Publication Date Title
ECSP099509A (es) Procedimiento para la preparación de un derivado de bencimidazol
WO2009095226A3 (en) NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS
WO2010136474A3 (en) Substituted aminobutyric derivatives as neprilysin inhibitors
UA98623C2 (ru) Соединения диосметина, способ их получения и фармацевтическая композиция, которая их содержит
WO2008147557A3 (en) Heteroaryl substituted thiazoles and their use as antiviral agents
NO20090328L (no) Nye forbindelser 385
EP1679309A4 (en) ANTISTRESS MEDICAMENT AND ITS MEDICAL USE
MX2010010647A (es) Proceso para preparar formulaciones de dabigatran para administracion oral.
MX2012012421A (es) Compuestos tetrahidrobenzotiofena.
NZ590355A (en) Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient
WO2008069917A3 (en) Novel cyclic peptides
MA29653B1 (fr) Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2011047055A8 (en) Novel mek inhibitors, useful in the treatment of diseases
JP2013103902A5 (https=)
CN101031562A (zh) 咪唑－5－羧酸类衍生物、制备方法及其应用
MX2007003913A (es) Alquil-piridinas como inhibidores de 11 beta para diabetes.
MX2011013130A (es) Nuevos compuestos de bencensulfonamida, metodo para sintetizarlos y su utilizacion en medicina asi como tambien en cosmeticos.
WO2014020405A8 (en) Cyclic urea- or lactam-substituted quinoxaline-type piperidine compounds and the uses thereof
WO2006117211A3 (en) Urea derivatives methods for their manufacture and uses thereof
WO2006131923A3 (en) Novel salts of conjugated psychotropic drugs and processes of preparing same
BR112014002734A2 (pt) "ligantes de receptor de estrogênio, composição farmacêutica que os compreende e usos dos mesmos"
MX2010004505A (es) Piperidinas 4,4-disustituidas.
JP2013103903A5 (https=)
JP2011527340A5 (https=)
WO2010018474A3 (fr) Nouveaux derives de glucopyranose, leur preparation et leurs applications biologiques